Site Search

1. 91.
   AMP/assets/File/pressreleases/2020/AMP_August_SARS_CoV_2_Survey.pdf?pass=28

   Overall, 54% of the respondents indicated ... experienced shortages in staff, with 66% noting shortages in qualified clinical laboratory technologists/scientists and 53% experiencing shortages in clinical laboratory ... Medicine To register, please visit https://educate.amp.org/local/catalog/ ... 2 Testing Survey, please visit: https://www.amp.org/advocacy/sars

   https://www.amp.org/AMP/assets/File/pressreleases/2020/AMP_August_SARS_CoV_2_Sur...
2. 92.
   AMPlificationsDecember2015

   The final determinations are available here: https://www.cms.gov/Medicare/Medicare- ... contact information may be found at: https://www.cms.gov/medicarecoverage-database/indexes ... at http://energycommerce.house.gov/hearing /%E2%80%9Cexamining-regulation-diagnostic-tests-and-laboratory ... Case Study Series. Go to https://connection.asco.org/discussion/lung-

   https://www.amp.org/AMP/assets/File/newsletter/AMPlificationsDecember2015.pdf?pa...
3. 93.
   AMP/assets/File/education/case-studies/0616-AMPCaseReport-LR.pdf?pass=37

   VYSIS EWSR1 break apart FISH probe kit. Abbott Molecular website. https://www. abbottmolecular.com/products/ ... in formalin-fixed tissues 11.6% 11 Not applicable Analytical sensitivity ... formalin-fixed, paraffinembedded tissues) 94%6,12–96%11,13 82%12–86%16 Clinical specificity (formalin-fixed, paraffinembedded tissues) 100%11,13 100%12 Test yourself Here

   https://www.amp.org/AMP/assets/File/education/case-studies/0616-AMPCaseReport-LR...
4. 94.
   AMP/assets/File/advocacy/AMP comments on FDASLA 5-22-2022.pdf?pass=6

   See here for information on AMP’s positions: https://www.amp.org/advocacy/laboratory- ... transfer, design history file, 2 https://www.accessdata.fda.gov/scripts ... mitigate testing delays, approximately 35% of the laboratory professionals surveyed ... a sliver of the 3 https://www.amp.org/advocacy/sars ... Accessed November 8, 2021 5 https://www.fda.gov/medical-devices

   https://www.amp.org/AMP/assets/File/advocacy/AMP comments on FDASLA 5-22-2022.pd...
5. 95.
   AMP/assets/File/position-statements/2017/JointCommentLettertoNoridioanJEforMultipl...

   The authors drew several conclusions from this research, including that 20% of patients experienced ... Clostridium difficile infections, 6% of patients developed infections ... resistant organisms, and 24% of patients had prolonged ... authors concluded that 19% of antibiotics prescribed in ... Tests for RespiratoryandGastrointestinal Pathogens. https://www.asm.org/index

   https://www.amp.org/AMP/assets/File/position-statements/2017/JointCommentLettert...
6. 96.
   AMP/assets/File/pressreleases/2020/AMP_SARS-CoV-2_Survey.pdf?pass=17

   CoV-2 testing to patients, while another 10% are currently in the test validation phase. 90% of the laboratories recognize the ... months. However, more than 70% of these laboratories have experienced ... Medicine. To register, please visit https://attendee.gotowebinar.com/register/475468817326070028 ... 2 Testing Survey, please visit https://www.amp.org/advocacy/sars

   https://www.amp.org/AMP/assets/File/pressreleases/2020/AMP_SARS-CoV-2_Survey.pdf...
7. 97.
   AMP/assets/File/advocacy/AMP-CAP Comment Letter on Respiratory Pathogen Panel...

   The authors drew several conclusions from this research, including that 20% of patients experienced ... developed Clostridium difficile infections, 6% of patients developed infections with ... resistant organisms, and 24% of patients had prolonged ... the authors concluded that 19% of antibiotics prescribed in this ... Rev. 863, 02-12-19 https://www.cms.gov/Regulations-and

   https://www.amp.org/AMP/assets/File/advocacy/AMP-CAP Comment Letter on Respirato...
8. 98.
   AMP/assets/File/committees/reports/2023_Annual_Committee_and_Subdivision_Reports...

   Frederick Nolte. DOI: https://doi.org/10.1016/j.jmoldx. ... CPIC and PharmGKB representative). DOI: https://doi.org/10.1016/j.jmoldx. ... Smolkin, and Stephen Lincoln. DOI: https://doi.org/10.1016/j.jmoldx ... CPC initiatives are always welcome! Visit https://www.amp.org/clinical-practice/clinical ... total of 79 people, 16 (20%) of which were from outside of

   https://www.amp.org/AMP/assets/File/committees/reports/2023_Annual_Committee_and...
9. 99.
   AMP/assets/File/clinical-practice/GermlineValidationTables.xlsx?pass=56

   For diagnostic tests, both the %FPs that are potentially reportable ... flagged veriants is low( ~10-20%) the difference will be modest. For ... an observed aPPV of 100% (column B) Copyright 2023. The ... for further details. Published online at https://www.amp.org/resources/validation-resources ... the white paper referenced above. https://doi.org/10.1016/j.jmoldx.

   https://www.amp.org/AMP/assets/File/clinical-practice/GermlineValidationTables.x...
10. 100.
    AMP/assets/File/awards/young_investigator/YIA2014_WinningAbstracts.pdf?pass=52

    V3 kits were 91% to 96.5% for read 1 and 89% to 95% for read 2. Intra-run and inter-run ... a measure of assay accuracy, showed a 100% base matching rate with the tumor clone sequence ... exclusive RAS-BRAF mutations were identified in 82% of cases. BRAF V600E was the most common mutation, found in 62% of ameloblastomas as well as in ameloblastic fibromas

    https://www.amp.org/AMP/assets/File/awards/young_investigator/YIA2014_WinningAbs...